| Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy RA Gardner, F Ceppi, J Rivers, C Annesley, C Summers, A Taraseviciute, ... Blood, The Journal of the American Society of Hematology 134 (24), 2149-2158, 2019 | 262 | 2019 |
| Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells DA Lichtenstein, F Schischlik, L Shao, SM Steinberg, B Yates, HW Wang, ... Blood, The Journal of the American Society of Hematology 138 (24), 2469-2484, 2021 | 125 | 2021 |
| Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study W Sun, J Malvar, R Sposto, A Verma, JJ Wilkes, R Dennis, K Heym, ... Leukemia 32 (11), 2316-2325, 2018 | 125 | 2018 |
| Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia F Ceppi, C Langlois-Pelletier, V Gagné, J Rousseau, C Ciolino, ... Pharmacogenomics 15 (8), 1105-1116, 2014 | 107 | 2014 |
| Lymphocyte apheresis for chimeric antigen receptor T‐cell manufacturing in children and young adults with leukemia and neuroblastoma F Ceppi, J Rivers, C Annesley, N Pinto, JR Park, C Lindgren, S Mgebroff, ... Transfusion 58 (6), 1414-1420, 2018 | 95 | 2018 |
| Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia M Ben Tanfous, B Sharif-Askari, F Ceppi, H Laaribi, V Gagné, J Rousseau, ... Clinical Cancer Research 21 (2), 329-334, 2015 | 69 | 2015 |
| Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention F Ceppi, G Cazzaniga, A Colombini, A Biondi, V Conter Expert review of hematology 8 (1), 57-70, 2015 | 57 | 2015 |
| Infectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countries MA Caniza, C Odio, S Mukkada, M Gonzalez, F Ceppi, ... Expert review of hematology 8 (5), 627-645, 2015 | 49 | 2015 |
| The evolution and future of CAR T cells for B‐cell acute lymphoblastic leukemia CE Annesley, C Summers, F Ceppi, RA Gardner Clinical Pharmacology & Therapeutics 103 (4), 591-598, 2018 | 46 | 2018 |
| Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients R Abaji, V Gagné, CJ Xu, JF Spinella, F Ceppi, C Laverdière, JM Leclerc, ... Oncotarget 8 (27), 43752, 2017 | 45 | 2017 |
| Primary cutaneous lymphomas in children and adolescents F Ceppi, E Pope, B Ngan, O Abla Pediatric blood & cancer 63 (11), 1886-1894, 2016 | 37 | 2016 |
| Supportive medical care for children with acute lymphoblastic leukemia in low-and middle-income countries F Ceppi, F Antillon, C Pacheco, CE Sullivan, CG Lam, SC Howard, ... Expert review of hematology 8 (5), 613-626, 2015 | 34 | 2015 |
| Improvement of the outcome of relapsed or refractory acute lymphoblastic leukemia in children using a risk-based treatment strategy F Ceppi, M Duval, JM Leclerc, C Laverdiere, YL Delva, S Cellot, P Teira, ... PLoS One 11 (9), e0160310, 2016 | 33 | 2016 |
| Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward K Jenei, Z Aziz, C Booth, B Cappello, F Ceppi, EGE de Vries, A Fojo, ... The Lancet Global Health 10 (12), e1860-e1866, 2022 | 32 | 2022 |
| Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencing R Abaji, F Ceppi, S Patel, V Gagné, CJ Xu, JF Spinella, A Colombini, ... Pharmacogenomics 19 (15), 1181-1193, 2018 | 32 | 2018 |
| Safety and efficacy of intrathecal rituximab in children with B cell lymphoid CD20+ malignancies: an international retrospective study F Ceppi, S Weitzman, W Woessmann, K Davies, A Lassaletta, ... American Journal of Hematology 91 (5), 486-491, 2016 | 32 | 2016 |
| Bim Polymorphisms: Influence on Function and Response to Treatment in Children with Acute Lymphoblastic Leukemia V Gagné, J Rousseau, M Labuda, B Sharif-Askari, I Brukner, C Laverdiere, ... Clinical Cancer Research 19 (18), 5240-5249, 2013 | 30 | 2013 |
| Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents A Attarbaschi, O Abla, L Ronceray, S Bansil, S Bomken, B Burkhardt, ... Blood advances 3 (24), 4291-4297, 2019 | 25 | 2019 |
| Second malignant neoplasms after treatment of non-Hodgkin’s lymphoma—a retrospective multinational study of 189 children and adolescents A Attarbaschi, E Carraro, L Ronceray, M Andrés, S Barzilai-Birenboim, ... Leukemia 35 (2), 534-549, 2021 | 23 | 2021 |
| Hematología y oncología pediátricas LM Lopez, AL Atienza, JS Navarro, IA Aguirre, MB González, NB Gómez, ... Ergón, 2015 | 23 | 2015 |
